KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Net Cash Flow (2018 - 2025)

ClearPoint Neuro's Net Cash Flow history spans 13 years, with the latest figure at -$3.3 million for Q3 2025.

  • For Q3 2025, Net Cash Flow rose 70.55% year-over-year to -$3.3 million; the TTM value through Sep 2025 reached $16.8 million, up 705.92%, while the annual FY2024 figure was -$3.1 million, 31.04% up from the prior year.
  • Net Cash Flow for Q3 2025 was -$3.3 million at ClearPoint Neuro, down from $29.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $44.8 million in Q1 2021 and bottomed at -$26.1 million in Q2 2022.
  • The 5-year median for Net Cash Flow is -$3.3 million (2025), against an average of $960631.6.
  • The largest annual shift saw Net Cash Flow plummeted 683.86% in 2022 before it surged 1270.73% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$3.5 million in 2021, then skyrocketed by 351.36% to $8.9 million in 2022, then tumbled by 113.5% to -$1.2 million in 2023, then dropped by 26.37% to -$1.5 million in 2024, then tumbled by 118.56% to -$3.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Net Cash Flow are -$3.3 million (Q3 2025), $29.4 million (Q2 2025), and -$7.7 million (Q1 2025).